Retirement and nonpension postretirement benefit obligations
West Pharmaceutical Services Retirement and nonpension postretirement benefit obligations decreased by 1.7% to $28.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.3%, from $28.60M to $28.50M. Over 5 years (FY 2020 to FY 2025), Retirement and nonpension postretirement benefit obligations shows a downward trend with a -12.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase may signal underfunded plans requiring future cash contributions, while a decrease suggests improved funding status.
Detailed definition
This represents the long-term liability associated with defined benefit pension plans and other post-retirement benefits...
Peer comparison
Highly dependent on legacy workforce size and plan structure; common in mature industrial manufacturing firms.
non_current_liabilities_pension_and_other_postretirement_0d4947Historical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $54.00M | $52.10M | $40.50M | $38.70M | $36.80M | $35.20M | $28.20M | $27.20M | $27.30M | $28.40M | $29.60M | $28.90M | $29.10M | $30.20M | $28.20M | $28.60M | $30.80M | $31.10M | $29.00M | $28.50M |
| QoQ Change | — | -3.5% | -22.3% | -4.4% | -4.9% | -4.3% | -19.9% | -3.5% | +0.4% | +4.0% | +4.2% | -2.4% | +0.7% | +3.8% | -6.6% | +1.4% | +7.7% | +1.0% | -6.8% | -1.7% |
| YoY Change | — | — | — | — | -31.9% | -32.4% | -30.4% | -29.7% | -25.8% | -19.3% | +5.0% | +6.3% | +6.6% | +6.3% | -4.7% | -1.0% | +5.8% | +3.0% | +2.8% | -0.3% |
Retirement and nonpension postretirement benefit obligations at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's retirement and nonpension postretirement benefit obligations?
- West Pharmaceutical Services (WST) reported retirement and nonpension postretirement benefit obligations of $28.50M in Q1 2026.
- How has West Pharmaceutical Services's retirement and nonpension postretirement benefit obligations changed year-over-year?
- West Pharmaceutical Services's retirement and nonpension postretirement benefit obligations decreased by 0.3% year-over-year, from $28.60M to $28.50M.
- What is the long-term trend for West Pharmaceutical Services's retirement and nonpension postretirement benefit obligations?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's retirement and nonpension postretirement benefit obligations has grown at a -12.8% compound annual growth rate (CAGR), from $57.50M to $29.00M.
- What does retirement and nonpension postretirement benefit obligations mean?
- Long-term obligations for employee pension and retirement benefits.